- Patent Number:
12201,832
- Appl. No:
17/656586
- Application Filed:
March 25, 2022
- Abstract:
A medical system for obstructive sleep apnea (OSA) treatment includes therapy delivery circuitry configured to output one or more electrical stimulation signals to a tongue of a patient; sensing circuitry configured to sense one or more compound muscle action potential (CMAP) signals, wherein the one or more CMAP signals are generated in response to the delivery of the one or more electrical stimulation signals; and processing circuitry configured to: cause the therapy delivery circuitry to output the one or more electrical stimulation signals to the tongue; receive information indicative of the one or more CMAP signals from the sensing circuitry; determine, based on the one or more CMAP signals, one or more therapeutic stimulation parameters for the OSA treatment; and cause the therapy delivery circuitry to deliver therapeutic electrical stimulation signals according to at least the determined one or more therapeutic stimulation parameters.
- Inventors:
Medtronic, Inc. (Minneapolis, MN, US)
- Assignees:
Medtronic, Inc. (Minneapolis, MN, US)
- Claim:
1. A medical system for obstructive sleep apnea (OSA) treatment, the system comprising: therapy delivery circuitry configured to output one or more electrical stimulation signals to a tongue of a patient via a first electrode configured to be implantable within the tongue; sensing circuitry configured to sense a plurality of compound muscle action potential (CMAP) signals via one or more second electrodes configured to be implantable within the tongue, wherein the plurality of CMAP signals are generated in response to the delivery of the one or more electrical stimulation signals; and processing circuitry configured to: cause the therapy delivery circuitry to output the one or more electrical stimulation signals to the tongue; determine, based on the plurality of CMAP signals, one or more therapeutic stimulation parameters for the OSA treatment, wherein to determine the one or more therapeutic stimulation parameters, the processing circuitry is configured to: determine a summed CMAP signal based on a summation of a first CMAP signal of the plurality of CMAP signals and a second CMAP signal of the plurality of CMAP signals, the first CMAP signal being evoked on a first side of the tongue, and the second CMAP signal being evoked on one of a second side of the tongue or on the first side of the tongue; compare the summed CMAP signal to a combined CMAP signal, the combined CMAP signal being simultaneously evoked on both the first side and the second side or evoked on the first side with stimulation from a plurality of electrodes on the first side; and determine, based on the comparison, the one or more therapeutic stimulation parameters; and cause the therapy delivery circuitry to deliver therapeutic electrical stimulation signals according to at least the determined one or more therapeutic stimulation parameters.
- Claim:
2. The medical system of claim 1 , further comprising an implantable medical device (IMD), wherein the IMD includes the therapy delivery circuitry, the sensing circuitry, and at least a portion of the processing circuitry.
- Claim:
3. The medical system of claim 1 , further comprising an implantable medical device (IMD) and an external programmer, wherein the IMD includes the therapy delivery circuitry and the sensing circuitry, and wherein the external programmer includes at least a portion of the processing circuitry.
- Claim:
4. The medical system of claim 1 , wherein to cause the therapy delivery circuitry to output the one or more electrical stimulation signals, the processing circuitry is configured to cause the therapy delivery circuitry to output a plurality of electrical stimulation signals having different energy.
- Claim:
5. The system of claim 1 , wherein to determine, based on the comparison, the one or more therapeutic stimulation parameters, the processing circuitry is configured to: determine whether there is cross-innervation based on the comparison; and determine the one or more therapeutic stimulation parameters based on whether there is cross-innervation.
- Claim:
6. The system of claim 1 , wherein the plurality of CMAP signals comprise a first set of CMAP signals, and wherein, subsequent to the delivery of the therapeutic electrical stimulation signals, the processing circuitry is configured to: compare two or more CMAP signals of a second set of CMAP signals to each other, the second set of CMAP signals being generated in response to the delivery of the therapeutic electrical stimulation signals; determine that the tongue is experiencing fatigue based on the comparison of the two or more CMAP signals of the second set of CMAP signals; and control the therapy delivery circuitry based on the determination that the tongue is experiencing fatigue.
- Claim:
7. The system of claim 6 , wherein to control the therapy delivery circuitry, the processing circuitry is configured to: update one or more of the one or more stimulation parameters to generate updated one or more stimulation parameters based on the comparison of the two or more CMAP signals of the second set of CMAP signals; and cause the therapy delivery circuitry to deliver updated therapeutic electrical stimulation signals based on the updated one or more stimulation parameters.
- Claim:
8. The system of claim 6 , wherein to control the therapy delivery circuitry, the processing circuitry is configured to: cause the therapy delivery circuitry to cease delivery of the therapeutic electrical stimulation signals.
- Claim:
9. The system of claim 6 , wherein to compare the two or more CMAP signals of the second set of CMAP signals to each other, the processing circuitry is configured to determine whether there is a change in one or more of an amplitude between the two or more of the second set of CMAP signals, a shape between the two or more of the second set of CMAP signals, and whether there is a change in a variance between the two or more of the second set of CMAP signals.
- Claim:
10. The system of claim 1 , further comprising an accelerometer configured to generate information, wherein the processing circuitry is configured to receive the information, and determine whether there is a change in patient posture based on the received information, and wherein the processing circuitry is configured to, in response to the determination that there is the change in patient posture: cause the therapy delivery circuitry to output the one or more electrical stimulation signals to the tongue; and determine the one or more therapeutic stimulation parameters based on the ene or more plurality of CMAP signals for the OSA treatment.
- Claim:
11. The system of claim 1 , wherein the each of the plurality of CMAP signals includes an artifact portion and a non-artifact portion, wherein to determine the one or more therapeutic stimulation parameters, the processing circuitry is configured to determine the one or more therapeutic stimulation parameters based on: both the artifact portion and the non-artifact portion; the non-artifact portion, and not the artifact portion; or the artifact portion, and not the non-artifact portion.
- Claim:
12. A method of obstructive sleep apnea (OSA) treatment, the method comprising: outputting, with therapy delivery circuitry, one or more electrical stimulation signals to a tongue of a patient via a first electrode configured to be implanted within the tongue; sensing, with sensing circuitry, a plurality of compound muscle action potential (CMAP) signals via one or more second electrodes configured to be implanted within the tongue, wherein the plurality of CMAP signals are generated in response to the delivery of the one or more electrical stimulation signals; determining, with processing circuitry and based on the plurality of CMAP signals, one or more therapeutic stimulation parameters for the OSA treatment, wherein determining the one or more therapeutic stimulation parameters comprises: determining a summed CMAP signal based on a summation of a first CMAP signal of the plurality of CMAP signals and a second CMAP signal of the plurality of CMAP signals, the first CMAP signal being evoked on a first side of the tongue, and the second CMAP signal being evoked on one of a second side of the tongue or on the first side of the tongue; comparing the summed CMAP signal to a combined CMAP signal, the combined CMAP signal being simultaneously evoked on both the first side and the second side or evoked on the first side with stimulation from a plurality of electrodes on the first side; and determining, based on the comparison, the one or more therapeutic stimulation parameters; and causing, with the processing circuitry, the therapy delivery circuitry to deliver therapeutic electrical stimulation signals according to at least the determined one or more therapeutic stimulation parameters.
- Claim:
13. The method of claim 12 , wherein causing the therapy delivery circuitry to output the one or more electrical stimulation signals comprises causing the therapy delivery circuitry to output a plurality of electrical stimulation signals having different energy.
- Claim:
14. The method of claim 12 , wherein determining, based on the comparison, the one or more therapeutic stimulation parameters comprises: determining whether there is cross-innervation based on the comparison; and determining the one or more therapeutic stimulation parameters based on whether there is cross-innervation.
- Claim:
15. The method of claim 12 , wherein the plurality of CMAP signals comprise a first set of CMAP signals, the method further comprising, subsequent to the delivery of the therapeutic electrical stimulation signals: comparing two or more CMAP signals of a second set of CMAP signals to each other, the second set of CMAP signals being generated in response to the delivery of the therapeutic electrical stimulation signals; determining that the tongue is experiencing fatigue based on the comparison of the two or more CMAP signals of the second set of CMAP signals; and controlling the therapy delivery circuitry based on the determination that the tongue is experiencing fatigue.
- Claim:
16. The method of claim 12 , wherein the each of the plurality of CMAP signals includes an artifact portion and a non-artifact portion, wherein determining the one or more therapeutic stimulation parameters comprises determining the one or more therapeutic stimulation parameters based on: both the artifact portion and the non-artifact portion; the non-artifact portion, and not the artifact portion; or the artifact portion, and not the non-artifact portion.
- Patent References Cited:
8594805 November 2013 Ordonez et al.
9757560 September 2017 Papay
10029098 July 2018 Papay
10065038 September 2018 Papay
10744339 August 2020 Makansi
2014/0243926 August 2014 Carcieri
2020/0269044 August 2020 Papay
2020/0282219 September 2020 Scheiner
2020/0338358 October 2020 Makansi
2020/0346017 November 2020 Caparso et al.
2021/0228872 July 2021 Scheiner et al.
2021/0290957 September 2021 Schulhauser et al.
3071288 November 2018
- Other References:
International Search Report and Written Opinion of International Application No. PCT/IB2023/052943 dated Jun. 27, 2023, 11 pp. cited by applicant
- Primary Examiner:
Stice, Paula J
- Attorney, Agent or Firm:
Shumaker & Sieffert, P.A.
- Accession Number:
edspgr.12201832
Processing Request
No Comments.